Activist investor Starboard met with Pfizer last week. Here's what went down, according to the hedge fund's cofounder and CEO ...

Salesforce (NYSE:CRM) shares jumped 98% in 2023 in part after the business software maker increased its adjusted operating margin after Starboard Value and other activist investors raised concerns ...

Despite that cash windfall, Pfizer has "dramatically underperformed its peers and the market since 2019," according to ...

TSMC has denied a report that the U.S. is investigating its dealings with Huawei, following news that one of its chips has ...

Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...

Activist investor Keith Meister is not embarrassed about lagging behind other corporate agitators, saying his rivals' work ...

Adds Kenvue comment. Kenvue (NYSE:KVUE) needs to focus on fixing its skin, health and beauty segments, Jeff Smith, founder ...

Activist investor Starboard Value urged Pfizer’s (PFE) leadership to do “something different” and hold management accountable ...

Starboard Value is raising the stakes in its $1 billion campaign for change at Pfizer (NYSE:PFE), urging the pharmaceutical ...

Jeff Smith says pharma giant’s returns from recent efforts are ‘not adequate’ in speech at 13D activist investor conference ...

Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job.